p53 as a significant prognostic marker in endometrial carcinoma

被引：0
作者：
Quddus, MR
Zheng, W
Sung, CJ
Lauchlan, SC
Felix, JC
机构：
[1] Brown Univ, Women & Infants Hosp, Dept Pathol, Providence, RI USA
[2] Univ So Calif, Womens & Childrens Hosp, Los Angeles, CA 90089 USA
来源：
MODERN PATHOLOGY | 1998年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：112A / 112A
页数：1
相关论文
共 50 条
[41]   P53 GENE-MUTATIONS IN HUMAN ENDOMETRIAL CARCINOMA [J].
RISINGER, JI ;
DENT, GA ;
IGNARTROWBRIDGE, D ;
MCLACHLAN, JA ;
TSAO, MS ;
SENTERMAN, M ;
BOYD, J .
MOLECULAR CARCINOGENESIS, 1992, 5 (04) :250-253
[42]   BAG3 interacts with p53 in endometrial carcinoma [J].
Margot De Marco ;
Jacopo Troisi ;
Luigi Giugliano ;
Alessandra Rosati ;
Antonio D’Antonio ;
Roberta Iaccarino ;
Mario Capunzo ;
Francesco Salzano ;
Rosanna Martinelli ;
Pierpaolo Cavallo ;
Maurizio Guida ;
Liberato Marzullo .
Cellular Oncology, 2020, 43 :957-960
[43]   Mutant p53 protein as a predictor of survival in endometrial carcinoma [J].
Strang, P ;
Nordstrom, B ;
Nilsson, S ;
Bergstrom, R ;
Tribukait, B .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (04) :598-602
[44]   BAG3 interacts with p53 in endometrial carcinoma [J].
De Marco, Margot ;
Troisi, Jacopo ;
Giugliano, Luigi ;
Rosati, Alessandra ;
D'Antonio, Antonio ;
Iaccarino, Roberta ;
Capunzo, Mario ;
Salzano, Francesco ;
Martinelli, Rosanna ;
Cavallo, Pierpaolo ;
Guida, Maurizio ;
Marzullo, Liberato .
CELLULAR ONCOLOGY, 2020, 43 (05) :957-960
[45]   The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study [J].
Athanassiadou, P. ;
Athanassiades, P. ;
Grapsa, D. ;
Gonidi, M. ;
Athanassiadou, A. M. ;
Stamati, P. N. ;
Patsouris, E. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) :697-704
[46]   Performance of p53 Immunohistochemistry as a Surrogate Marker for TP53 Mutations in the PORTEC-3 Endometrial Carcinoma Cohort [J].
Leon-Castillo, Alicia ;
Vermij, Lisa ;
de Boer, Stephanie ;
Singh, Naveena ;
Fyles, Anthony ;
Mclachlin, C. Meg ;
Leary, Alexandra ;
Nijman, Hans ;
Smit, Vincent ;
Nout, Remi ;
Horeweg, Nanda ;
Creutzberg, Carien ;
Bosse, Tjalling .
LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) :710-711
[47]   Performance of p53 Immunohistochemistry as a Surrogate Marker for TP53 Mutations in the PORTEC-3 Endometrial Carcinoma Cohort [J].
Leon-Castillo, Alicia ;
Vermij, Lisa ;
de Boer, Stephanie ;
Singh, Naveena ;
Fyles, Anthony ;
Mclachlin, C. Meg ;
Leary, Alexandra ;
Nijman, Hans ;
Smit, Vincent ;
Nout, Remi ;
Horeweg, Nanda ;
Creutzberg, Carien ;
Bosse, Tjalling .
MODERN PATHOLOGY, 2021, 34 (SUPPL 2) :710-711
[48]   Functional analysis of p53 gene and the prognostic impact of dominant-negative p53 mutation in endometrial cancer [J].
Sakuragi, N ;
Watari, H ;
Ebina, Y ;
Yamamoto, R ;
Steiner, E ;
Koelbl, H ;
Yano, M ;
Tada, M ;
Moriuchi, T .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (04) :514-519
[49]   The Histopathology of Carcinoma Breast with Special Reference to p53 Marker [J].
Balakrishnan, Meera .
JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (45A) :281-286
[50]   Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation [J].
Pizem, J ;
Cör, A ;
Gale, N .
HISTOPATHOLOGY, 2004, 45 (02) :180-186
12345